MONOCRYL Plus
by Johnson & Johnson International 132 variants
Ref MCP2023HModel MONOCRYL Plus Antibacterial Suture
Active
CE MDR
Valid until
25 Jul 2028
FDA recalls
Not applicable
Documents
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/MDR | Number0705031a0071857 10705031121058 | Date12 Mar 2026 | StatusActive |
Certificates
- MDR 730060 Active
Technical documentation EU MDR
- Certifier
- BSI Group The Netherlands B.V. 2797
- Issued
- 15 May 2026
- Expires
- 25 Jul 2028
- Reason
- Change approved
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
European Union — CE/MDR Active
Specification
- Device Name
- MONOCRYL Plus Antibacterial Poliglecaprone – 25 Monofilament Absorbable Suture
- Model / Reference
- MONOCRYL Plus Antibacterial Suture, MCP2023H
- Primary DI / UDI-DI
- 10705031121058
- Basic UDI-DI
- 0705031a0071857
- EMDN Code
- H010101030301 Poliglecaprone and derivatives with antibacterial monofilament with needle
- Device Class
- Class III
- EU market of registration
- Belgium
Manufacturer details
- EUDAMED SRN
- BE-MF-000008018
Other devices from Johnson & Johnson International
Properties
Other properties (10)
- Reusable: No
- Contains Latex: No
- Reprocessed: No
- CMR Substance: No
- Human-derived: No
- Human Tissues: No
- Animal Tissues: No
- Endocrine Disruptor: No
- Administering Medicine: No
- Measuring Function: No